芒果视频下载

精(jing)(jing)華制(zhi)(zhi)藥(yao)(yao)集(ji)團股份有限(xian)公(gong)(gong)司是由南通產(chan)控(kong)集(ji)團控(kong)股、國(guo)資(zi)(zi)監管(guan)的地方國(guo)有控(kong)股企業，由原南通中(zhong)誠制(zhi)(zhi)藥(yao)(yao)有限(xian)公(gong)(gong)司（南通中(zhong)藥(yao)(yao)廠）變更、重組(zu)南通制(zhi)(zhi)藥(yao)(yao)總(zong)廠（南通制(zhi)(zhi)藥(yao)(yao)廠、南通制(zhi)(zhi)藥(yao)(yao)二廠）優質(zhi)資(zi)(zi)源(yuan)，并吸收民營(ying)資(zi)(zi)本南通綜(zong)藝投資(zi)(zi)有限(xian)公(gong)(gong)司以及自然人投資(zi)(zi)設立。2010年2月在深交所中(zhong)小板掛(gua)牌上市(shi)，股票簡稱：精(jing)(jing)華制(zhi)(zhi)藥(yao)(yao)，證券代號(hao)：002349。

公司已(yi)有(you)(you)60多年的制(zhi)(zhi)藥(yao)(yao)(yao)(yao)(yao)歷(li)史，是一家(jia)綜合(he)性的現代化(hua)GMP制(zhi)(zhi)藥(yao)(yao)(yao)(yao)(yao)有(you)(you)限公司。目前擁有(you)(you)7個(ge)(ge)子公司，是一家(jia)集中(zhong)(zhong)(zhong)(zhong)藥(yao)(yao)(yao)(yao)(yao)制(zhi)(zhi)劑、中(zhong)(zhong)(zhong)(zhong)藥(yao)(yao)(yao)(yao)(yao)飲(yin)片(pian)、西(xi)藥(yao)(yao)(yao)(yao)(yao)制(zhi)(zhi)劑、醫藥(yao)(yao)(yao)(yao)(yao)中(zhong)(zhong)(zhong)(zhong)間體(ti)、化(hua)學(xue)原(yuan)料藥(yao)(yao)(yao)(yao)(yao)、生物(wu)制(zhi)(zhi)藥(yao)(yao)(yao)(yao)(yao)、保(bao)健品(pin)等(deng)生產、銷售和研(yan)發的綜合(he)型制(zhi)(zhi)藥(yao)(yao)(yao)(yao)(yao)企業集團。公司有(you)(you)中(zhong)(zhong)(zhong)(zhong)西(xi)藥(yao)(yao)(yao)(yao)(yao)品(pin)種(zhong)(zhong)(zhong)200余種(zhong)(zhong)(zhong)，中(zhong)(zhong)(zhong)(zhong)藥(yao)(yao)(yao)(yao)(yao)產品(pin)主要有(you)(you)享(xiang)譽海內(nei)外的經典名藥(yao)(yao)(yao)(yao)(yao)“五朵金花”王氏保(bao)赤(chi)丸、季德勝蛇(she)藥(yao)(yao)(yao)(yao)(yao)片(pian)、正柴胡飲(yin)顆(ke)(ke)粒(li)、大柴胡顆(ke)(ke)粒(li)、金蕎麥膠囊，以及(ji)固本咳喘片(pian)、暈可平糖漿、精血補片(pian)等(deng)，這些中(zhong)(zhong)(zhong)(zhong)藥(yao)(yao)(yao)(yao)(yao)品(pin)種(zhong)(zhong)(zhong)都有(you)(you)著廣泛的歷(li)史背景及(ji)深厚的文(wen)(wen)化(hua)底蘊，其(qi)(qi)中(zhong)(zhong)(zhong)(zhong)季德勝蛇(she)藥(yao)(yao)(yao)(yao)(yao)片(pian)、王氏保(bao)赤(chi)丸制(zhi)(zhi)作技藝均被列入國家(jia)非物(wu)質(zhi)文(wen)(wen)化(hua)遺產。原(yuan)料藥(yao)(yao)(yao)(yao)(yao)產品(pin)主要有(you)(you)苯巴比妥、撲(pu)米酮、氟(fu)尿(niao)嘧啶(ding)、保(bao)泰松(song)、氟(fu)胞(bao)嘧啶(ding)、吡羅昔康、替(ti)諾昔康、丙硫氧嘧啶(ding)、非那(nei)西(xi)丁、雙(shuang)嘧達莫以及(ji)其(qi)(qi)它(ta)醫藥(yao)(yao)(yao)(yao)(yao)中(zhong)(zhong)(zhong)(zhong)間體(ti)等(deng)。其(qi)(qi)中(zhong)(zhong)(zhong)(zhong)已(yi)有(you)(you)10個(ge)(ge)品(pin)種(zhong)(zhong)(zhong)通過(guo)國家(jia)GMP認(ren)(ren)證，5個(ge)(ge)品(pin)種(zhong)(zhong)(zhong)通過(guo)歐(ou)盟CEP認(ren)(ren)證，2個(ge)(ge)品(pin)種(zhong)(zhong)(zhong)通過(guo)澳大利亞GMP認(ren)(ren)證，3個(ge)(ge)品(pin)種(zhong)(zhong)(zhong)通過(guo)墨(mo)西(xi)哥官方認(ren)(ren)證，4個(ge)(ge)品(pin)種(zhong)(zhong)(zhong)獲(huo)得美國DMF注冊(ce)文(wen)(wen)件(jian) ，1個(ge)(ge)品(pin)種(zhong)(zhong)(zhong)獲(huo)得美國VMF注冊(ce)文(wen)(wen)件(jian)，并已(yi)通過(guo)美國FDA現場核(he)查。

精華制藥將會以“成為(wei)(wei)(wei)以傳世(shi)中(zhong)藥為(wei)(wei)(wei)核心特色的(de)(de)全(quan)國現代醫(yi)藥企業”為(wei)(wei)(wei)戰略目標，深入貫徹《關于(yu)促進中(zhong)醫(yi)藥傳承創新發(fa)展(zhan)的(de)(de)意見》精神，聚焦“五朵金花(hua)”傳世(shi)中(zhong)藥主業為(wei)(wei)(wei)主，特色化(hua)學原(yuan)料藥及化(hua)學制劑(ji)為(wei)(wei)(wei)輔的(de)(de)“雙輪驅動”的(de)(de)發(fa)展(zhan)戰略，依托品牌力和(he)渠道力，致(zhi)力于(yu)成為(wei)(wei)(wei)以傳世(shi)中(zhong)藥為(wei)(wei)(wei)核心特色的(de)(de)全(quan)國現代醫(yi)藥企業。